Announced Fri, 18 Jul · 21:30 IST

Appointment of Secretarial Auditor of the Company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

At the 40th Annual General Meeting held on 18 July 2025, shareholders approved the appointment of M/s. Nilesh Shah & Associates as the Secretarial Auditor of the company. The firm has been appointed for a first term of five consecutive financial years, covering FY2025 to FY2030 (from the 40th AGM to the conclusion of the 45th AGM). Nilesh Shah & Associates is a peer-reviewed firm of Company Secretaries with over 22 years of experience and has been associated with Jenburkt Pharmaceuticals for more than 10 years in the same capacity. The firm specializes in secretarial audit and corporate law matters.

Likely market impact

This is a routine governance disclosure with no material impact on shareholders or the stock price. It reflects continuity, as the appointed firm has served the company for over a decade, and strengthens compliance and corporate governance practices for the next five years.